Clinical Study

Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study

Table 1

Descriptive characteristics of the study participants according to gender: CASPIAN III Study.

VariablesBoys Girls Total value
Mean ± SDMean ± SDMean ± SD

Age (yrs)14.6 ± 2.414.7 ± 2.314.7 ± 2.40.24
Weight (kg)46.0 ± 13.248.4 ± 16.547.2 ± 15.0<0.01
Height (cm)151.8 ± 11.6156.5 ± 15.6154.1 ± 13.9<0.01
BMI (kg/m2)19.6 ± 4.1219.2 ± 4.019.4 ± 4.1<0.01
Waist (cm)67.5 ± 22.270.0 ± 19.468.8 ± 20.8<0.01
WHR0.45 ± 0.20.50 ± 0.20.47 ± 0.20.08
SBP (mmHg)101.5 ± 13.62104.9 ± 13.9103.2 ± 13.9<0.01
DBP (mmHg)64.8 ± 10.4766.9 ± 11.1165.8 ± 10.8<0.01
TC (mg/dL)151.1 ± 31.6145.5 ± 31.5148.4 ± 31.7<0.01
HDL-C (mg/dL)46.4 ± 14.245.9 ± 14.346.2 ± 14.20.24
LDL-C (mg/dL)86.1 ± 27.282.1 ± 44.384.1 ± 27.2<0.01
TG (mg/dL)94.2 ± 40.891.8 ± 44.393.0 ± 42.60.04
FBG (mg/dL)87 ± 14.788.3 ± 12.887.6 ± 13.8<0.01

WHR: waist to height ratio, BMI: body mass index (kg/m2), SBP: systolic blood pressure (mmHg), DBP: diastolic blood pressure (mmHg), TC: total cholesterol (mg/dL), HDL: high-density lipoprotein (mg/dL), LDL: low-density lipoprotein (mg/dL), TG: triglyceride (mg/dL), FBS: fasting blood glucose (mg/dL).